Ted Ashburn

Dr. Theodore (Ted) Ashburn is the President and CEO of Oncorus, Inc., a viral immunotherapies company focused on driving innovation to transform outcomes for cancer patients. Prior to joining Oncorus, Dr. Ashburn served as Head of Oncology Development at Moderna Therapeutics, Inc. He has held key leadership roles of increasing responsibility in preclinical and clinical development, business development, product strategy, manufacturing and operations at multiple emerging biotechnology, as well as established pharmaceutical companies including Sanofi Oncology and Genzyme. He started his career at Pfizer, Inc. He received his B.S. in chemistry and computer science from Ball State University, his Ph.D. in organic chemistry from the Massachusetts Institute of Technology and his M.D. from Harvard Medical School.